MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 Medical Technologies to Watch in 2015: Focused Ultrasound

Focused Ultrasound   Insightec's ExAblate Neuro uses focused ultrasound to treat essential tremor.

Imagine if brain tumor removal required only mild sedation and no hospital stay. That’s the promise of focused ultrasound technology, which combines real-time magnetic resonance imaging and an ultrasound transducer to noninvasively ablate tissue.

Approved around the world for indications such as cancer, chronic pain, and Parkinson’s disease, focused ultrasound is currently in clinical trials for the treatment of conditions including hypertension, tubal pregnancy, and obsessive-compulsive disorder. The technique is also being considered for treatment of Alzheimer’s disease, epilepsy, obesity, and diabetes, among other applications.

Israeli firm Insightec, which already has FDA-approved focused ultrasound devices to treat pain in bone cancer patients and uterine fibroids in women, received approval from the agency last year to trial its ExAblate Neuro for treatment of essential tremor. This year, the company opened centers in China and initiated a $50-million funding round.


TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.